USANA Health Sciences (NYSE:USNA) Trading Up 4.9% - Here's Why

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) shares rose 4.9% during mid-day trading on Tuesday . The stock traded as high as $35.82 and last traded at $35.62. Approximately 33,580 shares changed hands during trading, a decline of 60% from the average daily volume of 84,144 shares. The stock had previously closed at $33.94.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. StockNews.com upgraded shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Thursday, December 19th. DA Davidson upgraded shares of USANA Health Sciences to a "hold" rating in a research note on Friday.

USANA Health Sciences Trading Up 8.0 %

The stock has a market capitalization of $698.74 million, a price-to-earnings ratio of 12.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. The company's 50 day moving average is $37.89 and its 200 day moving average is $40.07.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.49 by $0.07. The firm had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the prior year, the firm earned $0.59 EPS. Analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

Institutional Trading of USANA Health Sciences

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Exchange Traded Concepts LLC boosted its position in shares of USANA Health Sciences by 4.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock worth $292,000 after purchasing an additional 322 shares in the last quarter. Martingale Asset Management L P boosted its stake in shares of USANA Health Sciences by 2.1% during the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company's stock worth $634,000 after acquiring an additional 340 shares in the last quarter. KBC Group NV increased its stake in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. Safe Harbor Fiduciary LLC purchased a new stake in USANA Health Sciences during the third quarter worth $30,000. Finally, Public Sector Pension Investment Board increased its position in shares of USANA Health Sciences by 5.4% in the second quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company's stock valued at $1,098,000 after buying an additional 1,242 shares in the last quarter. Hedge funds and other institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.